Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
OMER
Omeros Corporation |
$11.95 | $847.61 M | -5.92 | 202 |
OCGN
Ocugen, Inc. |
$1.52 | $497.53 M | -6.91 | 95 |
MNPR
Monopar Therapeutics Inc. |
$67.34 | $444.79 M | -16.81 | 14 |
LXRX
Lexicon Pharmaceuticals, Inc. |
$1.44 | $521.48 M | -7.55 | 103 |
KALV
KalVista Pharmaceuticals, Inc. |
$15.65 | $791.05 M | -3.97 | 150 |
GOSS
Gossamer Bio, Inc. |
$2.42 | $560.12 M | -3.51 | 144 |
FULC
Fulcrum Therapeutics, Inc. |
$10.94 | $591.44 M | -9.59 | 45 |
FDMT
4D Molecular Therapeutics, Inc. |
$8.97 | $418.92 M | -2.39 | 227 |
CRVS
Corvus Pharmaceuticals, Inc. |
$20.94 | $1.56 B | -38.72 | 31 |
BCYC
Bicycle Therapeutics plc |
$6.52 | $450.72 M | -1.8 | 305 |